tiprankstipranks
Moderna (MRNA)
NASDAQ:MRNA
US Market

Moderna (MRNA) Technical Analysis

Compare
16,916 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Moderna’s (MRNA) Moving Averages Convergence Divergence (MACD) indicator is -1.66, suggesting Moderna is a Sell.
Moderna’s (MRNA) 20-Day exponential moving average is 35.32, while Moderna’s (MRNA) share price is $33.73, making it a Sell.
Moderna’s (MRNA) 50-Day exponential moving average is 39.09, while Moderna’s (MRNA) share price is $33.73, making it a Sell.

Moderna (MRNA) Pivot Points

Feb 21, 2025, 02:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
33.35
34.20
35.05
35.90
36.75
37.60
38.45
Fibonacci
34.20
34.85
35.25
35.90
36.55
36.95
37.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Moderna (MRNA) Moving Averages

Feb 21, 2025, 02:58 PM
Period
Simple
Exponential
MA5
34.06Sell
34.10Sell
MA10
32.98Buy
34.16Sell
MA20
36.36Sell
35.32Sell
MA50
38.68Sell
39.09Sell
MA100
44.89Sell
48.33Sell
MA200
77.90Sell
72.39Sell
Moderna’s (MRNA) 10-Day exponential moving average is 34.16, while Moderna’s (MRNA) share price is $33.73, making it a Sell.
Moderna’s (MRNA) 100-Day exponential moving average is 48.33, while Moderna’s (MRNA) share price is $33.73, making it a Sell.
Moderna’s (MRNA) stock price is $33.73 and Moderna’s (MRNA) 50-day simple moving average is 38.68, creating a Sell signal.
Moderna’s (MRNA) stock price is $33.73 and Moderna’s (MRNA) 100-day simple moving average is 44.89, creating a Sell signal.
Moderna’s (MRNA) stock price is $33.73 and Moderna’s (MRNA) 200-day simple moving average is 77.90, creating a Sell signal.

Moderna (MRNA) Technical Indicators

Feb 21, 2025, 02:58 PM
Name
Value
Implied Action
RSI (14)
43.92
Neutral
STOCH (9,6)
76.02
Neutral
STOCHRSI (14)
42.90
Neutral
MACD (12,26)
-1.66
Sell
ADX (14)
15.09
Buy
Williams %R
-63.31
Buy
CCI (14)
-38.96
Neutral
ATR (14)
2.88
-
Ultimate Oscillator
51.57
Neutral
ROC
-17.81
Sell
Moderna’s (MRNA) Relative Strength Index (RSI) is 43.92, creating a Neutral signal.
Moderna’s (MRNA) Trend Strength Indicator (ADX) is 15.09, creating a Buy signal.
Moderna’s (MRNA) Commodity Channel Index (CCI) is -38.96, creating a Neutral signal.
Moderna’s (MRNA) Price Rate of Change (ROC) is -17.81, creating a Sell signal.

FAQ

Is MRNA a Buy, Hold, or Sell?
Based on MRNA’s technical indicators, MRNA is a Sell.
    What is MRNA’s RSI (14)?
    MRNA’s RSI (14) is 43.92, which suggests MRNA is a Neutral.
      What is MRNA’s MACD?
      MRNA’s MACD is -1.66, which suggests MRNA is a Sell.
        What is MRNA’s 5-day moving average?
        MRNA’s 5-day moving average is 34.06, which suggests MRNA is a Sell.
          What is MRNA’s 20-day moving average?
          MRNA 20-day moving average is 36.36, which suggests MRNA is a Sell.
            What is MRNA’s 50-day moving average?
            MRNA’s 50-day moving average is 38.68, which suggests MRNA is a Sell.
              What is MRNA’s 200-day moving average?
              MRNA’s 200-day moving average is 77.90, which suggests MRNA is a Sell.
                What is MRNA’s Williams % R (14)?
                MRNA’s Williams % R (14) is -63.31, which suggests MRNA is a Buy.
                  What is MRNA’s CCI (14)?
                  MRNA’s CCI (14) is -38.96, which suggests MRNA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis